
After five exits, the Colorado founder chose a harder material problem: turning microalgae, mineral chemistry and patient commercialization into concrete with a smaller carbon bill.

The Irish chemical engineer spent a career turning laboratory ideas into businesses. Now he is betting that a straight magnetic bottle, Wisconsin manufacturing, and patient capital can make fusion useful.

Thomas Han spent decades learning how medicines move from a promising idea to a durable business. At Peroxitech, he is applying that education to the hardest hand-off in biotech: turning university science into a company that can keep moving.

She met graphene in an MBA classroom, built a company with her husband, and spent a decade translating microscopic chemistry into products manufacturers could actually use. Now MITO's sale to First Graphene gives that patient work a global runway.